ARTICLE | Clinical News
TH begins Phase II with ThGRF
March 6, 2001 8:00 AM UTC
Theratechnologies (TSE:TH) began a Canadian Phase II trial of its ThGRF peptide growth hormone releasing analog in 90 patients with chronic obstructive pulmonary disease (COPD). The trial will assess ...